IR
BIO icon

Invictus RG’s Bio-Rad Laboratories Class A BIO Stock Holding History

Invictus RG’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-843
Closed -$264K – 23
2018
Q3 		$264K Sell
843
-86
-9% -$26.7K 0.2% 158
2018
Q2 		$268K Sell
929
-63
-6% -$17.4K 0.23% 145
2018
Q1 		$248K Buy
+992
New +$253K 0.17% 212
2017
Q3 		– Sell
-1,774
Closed -$401K – 506
2017
Q2 		$401K Buy
+1,774
New +$387K 0.29% 113
2016
Q1 		– Sell
-36
Closed -$5K – 597
2015
Q4 		$5K Buy
+36
New +$4.99K ﹤0.01% 553

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return